The AEX index- for the Amsterdam Exchanges index – is an index composed of the 25 largest Dutch companies listed on the Amsterdam Stock Exchange. Since April, it has been in a bearish trend as evidenced by a succession of troughs ...
Day By Day – Indipendent Research
Sign up for our weekly Newsletter and receive the latest ETF and ETC news.
Click here to register for your free copy
and peakswhich are lower and lower and guided by the 50-day moving average. This dynamic was stopped by the strong support at 265 points, which has built a foundation base. A significant recovery can henceforth be envisioned, so we are therefore bullish in the medium-term.
| Close price | 288.31 |
| 2 months Opinion | BULLISH |
| 2 weeks Opinion | POSITIVE |
| Resistances | 295,7 / 300,9 pts |
| Supports | 284,1 / 276,1 pts |
Anticipation :
| Traker’s Name | Leverage | Expense ratio |
| AMUNDI ETF MSCI NETHERLANDS | x1 | 0,25% |
| ETFX AEX Fund | x1 | 0,30% |
| iShares AEX | x1 | 0,30% |
| Lyxor ETF Leverage AEX | x1 | 0,40% |
| SPDR AEX Index ETF | x1 | 0,30% |
| Think AEX Tracker | x1 | 0,30% |
Follow-up Analysys: Our DBD Tracker dated 03/10/2011 recommended the purchase of a pullback in the Dow Jones Industrial Average. Since then, the scenario unrolls as anticipated and currently offers a performance of 4.8%.
DISCAIMER
This publication is solely intended as information and does not constitute any investment advice or an offer, solicitation or recommendation to acquire or dispose of any investment or to engage in any transaction. Althoughthis publicationis issued in good faith, no representation or warranty, express or implied, is or willbe made and no responsibility or liability is or willbe accepted by NYSE Euronext or by any of its officers, employees or agents in relation to the accuracy or completeness of this publicationand any such liability is expressly disclaimed.No information set out or referred to in this publicationshall form the basis of any contract. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by NYSE Euronext’s subsidiaries shall depend solely on the applicable rules of the market operator. NYSE Euronext encourages you to reach your own opinion as to whether investments are appropriate or relevant and recommends you not to make any decisions on the basis of the information contained in this publication before checking it, as you will bear full responsibility for any use that you make of it. Persons wishingto trade products available on NYSE Euronextmarkets or wishingto offer such products to third parties are advised, before doing so, to check their legal and regulatory position in the relevant territory and to understand the related risks. All proprietary rights and interest in or connected with this publicationare vested in NYSE Euronext.No part of it may be redistributed or reproduced in any form or by any means or used to make any derivative work (such as translation, transformation, or adaptation) without the prior written permission of NYSE Euronext. NYSE Euronext refers to NYSE Euronext and its affiliates and references to NYSE Euronext in this publication include each and any such company as the context dictates. NYSE EuronextSM, Euronext®, trackers®, are registered marks of NYSE Euronext.
Source: ETFWorld – Day By Day – Indipendent Research
Subscribe to Our Newsletter
